Due to health issues, this site is no longer maintained and will be shut down shortly. |
Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:GLPG.
$37.32 -0.23 (-0.61%)
As of 03/27/2023 12:48:25 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.